RTX A/S
Noerresundby, Denmark, 15 January 2021
Announcement no. 03/2021
The Board of Directors of RTX has, cf. company announcement no. 38 dated 25. November 2020, resolved to initiate a share buy-back programme in accordance with the provisions of Article 5 Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (MAR) and the Commission’s delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the "Safe Harbor" rules.
Under the programme RTX will buy back shares for an amount up to DKK 50 million and no more than 500,000 shares in the period from 25 November 2020 to 30 September 2021.
The following transactions have been made under the programme in the period from 8 January 2021 to 14 January 2021:
Number of
shares |
Average
purchase price |
Transaction
value in DKK |
|
Accumulated, latest announcement | 38,200 | 223.50 | 8,537,705 |
8 January 2021 | 1,000 | 237.75 | 237,750 |
11 January 2021 | 1,000 | 238.00 | 238,000 |
12 January 2021 | 800 | 239.20 | 191,360 |
13 January 2021 | 800 | 243.65 | 194,920 |
14 January 2021 | 700 | 243.00 | 170,100 |
Accumulated under the programme | 42,500 | 225.17 | 9,569,835 |
With the transactions stated above, RTX A/S owns a total of 344,022 of treasury shares, corresponding to 3.98% of the share capital. The total number of shares in the company is 8,642,838 including treasury shares.
In accordance with the Regulation (EU) No. 596/2014, transactions related to the share buy-back programme are presented in detailed form in the appendix attached to this company announcement.
Enquiries and further information:
CEO Peter Røpke, tel +45 96 32 23 00
RTX’s homepage:
www.rtx.dk
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S17.9.2025 23:05:02 CEST | Press release
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Biogen Inc.17.9.2025 22:30:05 CEST | Press release
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Atico Mining Corporation17.9.2025 22:30:00 CEST | Press release
Atico Signs the Investment Protection Agreement with Government of Ecuador for its La Plata Project
Frontline plc.17.9.2025 22:06:51 CEST | Press release
FRO – Filing of Half Yearly Report
VCI Global Limited17.9.2025 21:00:00 CEST | Press release
VCI Global Initiates Rescission and Cancellation of Shares from QuantGold Transaction, Tightening Capital Structure Following Reverse Split
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom